VPM
XFOR icon

Vanguard Portfolio Management’s X4 Pharmaceuticals XFOR Stock Holding History

Vanguard Portfolio Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.53M Buy
+542,128
New +$2.22M ﹤0.01% 2664

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Portfolio Management's XFOR Position: Q2 2026 in Review

Vanguard Portfolio Management opened a new position in X4 Pharmaceuticals (XFOR) in Q2 2026: 542,128 shares worth $2.53M. The stake represents ﹤0.01% of the portfolio and ranks #2664 among its holdings.

52 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Vanguard Portfolio Management held 542,128 shares of X4 Pharmaceuticals worth $2.53M as of Q2 2026.
  • X4 Pharmaceuticals was a new Vanguard Portfolio Management position in Q2 2026.
  • X4 Pharmaceuticals made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2664 holding.
  • 52 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.